Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
Anas Younes, Anna Sureda, Dina Ben-Yehuda, Pier Luigi Zinzani, Tee-Chuan Ong, H Miles Prince, Simon J Harrison, Mark Kirschbaum, Patrick Johnston, Jennifer Gallagher, Christophe Le Corre, Angela Shen, Andreas Engert
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2012
Awarded by National Cancer Institute Lymphoma Specialized Programs of Research Excellence Grant
Research Funding: Anas Younes, Genentech, S*BIO, Novartis, Syndax Pharmaceuticals, sanofi-aventis; H. Miles Prince, Novartis; Simon J. Harrison, Novartis; Andreas Engert, NovartisSupported by Novartis Pharmaceuticals for clinical studies and medical editorial assistance and by National Cancer Institute Lymphoma Specialized Programs of Research Excellence Grant No. 1P50CA136411-01A1 to A.Y.